Neomycin + Nystatin + Thiostrepton + Triamcinolone Acetonide
75 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
75
Total Reports
2
Deaths Reported
270.0%
Death Rate
Active Ingredients
NeomycinNystatinThiostreptonTriamcinolone Acetonide
Administration Routes
Auricular (Otic)TopicalUnknownOralOphthalmic
Species Affected
Dog 63
Cat 8
Unknown 4
Most Affected Breeds
Chihuahua 8
Domestic Shorthair 7
Unknown 4
Dog (unknown) 3
Retriever - Golden 3
Retriever - Labrador 3
Bulldog - French 3
Pug 3
Shih Tzu 3
Terrier - Yorkshire 3
Most Reported Reactions
Deafness 24
Partial deafness 6
Lack of efficacy - NOS 5
Vomiting 5
Loss of hearing 5
Accidental exposure 5
Ear discharge 5
Lethargy (see also Central nervous system depression in Neurological) 5
Diarrhoea 4
Not eating 4
Polydipsia 3
Temporary deafness 3
Outcome Breakdown
Outcome Unknown
24 (33.8%)
Recovered with Sequela
23 (32.4%)
Recovered/Normal
20 (28.2%)
Ongoing
2 (2.8%)
Euthanized
2 (2.8%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.